Company Overview

Company name: Pedanios
Description: Provider of pharmaceutical wholesale services intended to provide licensed narcotic drugs. The company’s pharmaceutical wholesale services pays attention to high quality medicines, enabling dealers to get the highest quality medicine to patients by selection of producers, an extensive network of internal and external quality and safety measures and the cooperation with specialized logistics partners for the delivery of the products.
Year founded: 2015
Parent company: Aurora Cannabis
Industry: Consumer Products and Services (B2C) | Group: Retail | Code:
Website: www.pedanios.de
Employees: 7
City: Berlin
State:
Country: Germany
Region: Europe

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged (Operating Subsidiary)
Exchange:
Ticker:
Revenue (USD Million): 3.78
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: FY 2017
Financing Status: The company was acquired by Aurora Cannabis (TSX: ACB) for $20.88 million on May 26, 2017. The acquisition will enable the acquirer to expand its medical cannabis distribution business in the European Union.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 20.88
Last known valuation date: 26-May-2017